Home / Products / Cancer (Tumor) Cell Lines / RPMI-2650
RPMI-2650
Datasheet Protocol

RPMI-2650

Cat. No. ARC0781
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Nose (nasal septum)

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

RPMI-2650 is a cancer cell line of nose (nasal septum) nut carcinoma, isolated from metastatic; pleural effusion.

Recommended Products

ATM Knockout K562 Polyclonal Cells ATM Knockout K562 Polyclonal Cells Cat. No. ARG20256 AGPS Knockout HAP1 Polyclonal Cells AGPS Knockout HAP1 Polyclonal Cells Cat. No. ARG21738 HMGN4 Knockout Hela Polyclonal Cells HMGN4 Knockout Hela Polyclonal Cells Cat. No. ARG25885 CALU Knockout HAP1 Polyclonal Cells CALU Knockout HAP1 Polyclonal Cells Cat. No. ARG27467 CIDEB Knockout HCT116 Polyclonal Cells CIDEB Knockout HCT116 Polyclonal Cells Cat. No. ARG7112 GIGYF2 Knockout HEK293T Polyclonal Cells GIGYF2 Knockout HEK293T Polyclonal Cells Cat. No. ARG3335
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Nose (nasal septum)
Disease:
NUT carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
52 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CLPB Knockout A2780 Polyclonal Cells

CLPB Knockout A2780 Polyclonal Cells

Cat. No. ARG18351
 DYNLT3 Knockout HAP1 Polyclonal Cells

DYNLT3 Knockout HAP1 Polyclonal Cells

Cat. No. ARG40187
 NSD3 Knockout CaSki Polyclonal Cells

NSD3 Knockout CaSki Polyclonal Cells

Cat. No. ARG9816
 PDXP Knockout MES-OV Polyclonal Cells

PDXP Knockout MES-OV Polyclonal Cells

Cat. No. ARG5787
 MYLK4 Knockout HEK293T Polyclonal Cells

MYLK4 Knockout HEK293T Polyclonal Cells

Cat. No. ARG3972
 MYO1C Knockout Raji Polyclonal Cells

MYO1C Knockout Raji Polyclonal Cells

Cat. No. ARG944